| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |